BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xin S, Mao J, Duan C, Wang J, Lu Y, Yang J, Hu J, Liu X, Guan W, Wang T, Wang S, Liu J, Song W, Song X. Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma. Front Genet 2022;13:832046. [DOI: 10.3389/fgene.2022.832046] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Liu X, Qi Y, Liu Y, Du E, Zhang Z. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma. Front Immunol 2022;13:922929. [DOI: 10.3389/fimmu.2022.922929] [Reference Citation Analysis]
2 Miao Y, Liu J, Liu X, Yuan Q, Li H, Zhang Y, Zhan Y, Feng X. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma. Front Genet 2022;13:951239. [DOI: 10.3389/fgene.2022.951239] [Reference Citation Analysis]
3 Zhang G, Chen X, Fang J, Tai P, Chen A, Cao K. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma. Front Immunol 2022;13:954440. [DOI: 10.3389/fimmu.2022.954440] [Reference Citation Analysis]
4 Ren H, Zheng J, Cheng Q, Yang X, Fu Q. Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma. Front Genet 2022;13:900713. [DOI: 10.3389/fgene.2022.900713] [Reference Citation Analysis]
5 Dai J, Fu Y. Identification of necroptosis‐related gene signature and characterization of tumour microenvironment infiltration in non‐small‐cell lung cancer. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17494] [Reference Citation Analysis]
6 Wang W, Ye Y, Zhang X, Ye X, Liu C, Bao L. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma. Front Mol Biosci 2022;9:937979. [DOI: 10.3389/fmolb.2022.937979] [Reference Citation Analysis]
7 Liu D, Xu S, Chang T, Ma S, Wang K, Sun G, Chen S, Xu Y, Zhang H. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Front Immunol 2022;13:916800. [DOI: 10.3389/fimmu.2022.916800] [Reference Citation Analysis]
8 Luo Y, Zhang G. Identification of a Necroptosis-Related Prognostic Index and Associated Regulatory Axis in Kidney Renal Clear Cell Carcinoma. IJGM 2022;Volume 15:5407-23. [DOI: 10.2147/ijgm.s367173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]